From September 1 to 3, 2026, Pharmaconex 2026, the most authoritative and professional full-scale pharmaceutical exhibition in the Middle East and North Africa (MENA) region, was successfully held at the Cairo International Convention & Exhibition Centre. Centering on the localization, compliance and intelligent upgrading of the regional pharmaceutical industry, the exhibition gathers high-quality upstream and downstream pharmaceutical resources worldwide, serving as a vital platform for cross-border business cooperation and technical exchange between Chinese pharmaceutical intelligent manufacturing and the MENA market.

As a comprehensive pharmaceutical industrial chain service provider, Zhejiang Huli (WeCaps) showcased its one-stop pharmaceutical solutions including high-end hollow capsules, compliant APIs, nutritional vitamins and full-range intelligent pharmaceutical machinery at Booth H4.J25. During the three-day exhibition, the professional sales team of WeCaps actively carried out precise business docking,conducting in-depth business negotiations and technical exchanges with more than 30 local pharmaceutical enterprises and cross-border merchants in Egypt and North Africa. A number of preliminary cooperation intentions were reached covering product adaptation, quality compliance, supply chain matching and production line upgrading, achieving fruitful market expansion results.

Egypt is vigorously promoting the localization of pharmaceutical manufacturing, reducing reliance on imported medicines, and accelerating the large-scale development of generic drugs, health supplements and veterinary pharmaceuticals. This industrial transformation has driven a robust market demand for highly compliant and safe pharmaceutical excipients, hollow capsules, premium raw materials and intelligent production equipment. Targeting the industrial characteristics, regulatory standards and actual production demands of North Africa, WeCaps presented differentiated core products to precisely meet market requirements.
WeCaps supplies premium gelatin capsules and HPMC plant-based capsules with ETO-free and TiO₂-free high-purity formulas, fully complying with local halal standards and the production specifications of generic drugs and dietary supplements. The exhibited APIs and vitamin series feature stable quality and high compliance, covering mainstream pharmaceutical raw materials and full-spectrum nutritional vitamins. In addition, the company displayed complete intelligent production equipment for capsule filling, tableting, blister packaging, carton sealing and liquid filling, providing systematic upgrading solutions for pharmaceutical enterprises of all scales.

With 40 years of experience in hollow capsule R&D and manufacturing, mature global API supply chain resources and independent R&D capabilities for pharmaceutical equipment, WeCaps has built a complete pharmaceutical industrial chain system. Covering 108 countries and regions worldwide and equipped with an overseas service center in Nigeria, the company delivers efficient localized services and reliable one-stop supply chain solutions to empower the cost reduction and efficiency improvement of local pharmaceutical enterprises in North Africa. Customized cooling fans and cooling balms were prepared for on-site guests, winning wide recognition from industry partners.

The successful conclusion of Pharmaconex 2026 marks a key milestone in WeCaps’ in-depth layout of the North African market. The company will follow up all intentional clients promptly and launch customized solutions tailored to local regulatory policies and production conditions to accelerate cooperation implementation. Moving forward, WeCaps will continue to deepen global market layout, empower the high-quality development of the MENA pharmaceutical industry with superior products and professional services, and build a win-win cross-border industrial ecosystem with global partners.